Trials / Completed
CompletedNCT01376193
Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study is designed to investigate the information on safety and efficacy of naratriptan tablets on Japanese subjects with migraine headache during Japanese post-marketing surveillance period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naratriptan | Collection of safety data |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-06-20
- Last updated
- 2013-05-20
Source: ClinicalTrials.gov record NCT01376193. Inclusion in this directory is not an endorsement.